Skip to main content
Premium Trial:

Request an Annual Quote

Tesis Biosciences Acquires Genome Explorations

NEW YORK — Targeted genetic sequencing company Tesis Biosciences said on Wednesday that it has acquired Genome Explorations, a provider of genomic profiling and molecular diagnostic services.

Scottsdale, Arizona-based Tesis — which recently changed its name from Tesis Labs to reflect its increasing focus on clinical research and diagnostic initiatives — said that the acquisition would help it complete a clinical therapeutic project that could result in a commercialized product early this year.

Financial and other terms of the transaction were not disclosed.

"We have a number of proprietary clinical initiatives this acquisition allows us to complete by integrating Genome Explorations' ongoing research data with Tesis," Tesis CEO Ron King said in a statement. "By enabling clinicians to individualize treatment for people with cancer and other chronic diseases, we can improve the quality of life for millions of Americans and revolutionize medicine."

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.